Investigational new drugs submitted to the Food and Drug Administration that are placed on clinical hold: the experience of the Office of Cellular, Tissue and Gene Therapy.

MLA

Wonnacott, K., et al. “Investigational New Drugs Submitted to the Food and Drug Administration That Are Placed on Clinical Hold: The Experience of the Office of Cellular, Tissue and Gene Therapy.” Cytotherapy (Taylor & Francis Ltd), vol. 10, no. 3, June 2008, pp. 312–16. EBSCOhost, https://doi.org/10.1080/14653240801910905.

APA

Wonnacott, K., Lavoie, D., Fiorentino, R., McIntyre, M., Huang, Y., & Hirschfeld, S. (2008). Investigational new drugs submitted to the Food and Drug Administration that are placed on clinical hold: the experience of the Office of Cellular, Tissue and Gene Therapy. Cytotherapy (Taylor & Francis Ltd), 10(3), 312–316. https://doi.org/10.1080/14653240801910905

Chicago

Wonnacott, K., D. Lavoie, R. Fiorentino, M. McIntyre, Y. Huang, and S. Hirschfeld. 2008. “Investigational New Drugs Submitted to the Food and Drug Administration That Are Placed on Clinical Hold: The Experience of the Office of Cellular, Tissue and Gene Therapy.” Cytotherapy (Taylor & Francis Ltd) 10 (3): 312–16. doi:10.1080/14653240801910905.